
Sasho Klekovski
Sasho Klekovski is the acting director of the Health Insurance Fund of Macedonia. Recently, he addressed the issue of a shortage of biological therapy medications at the Clinic for Radiotherapy and Oncology, indicating that only one medication is currently in distributor defect. He anticipates that the annual procurement of medications will be announced by the end of the week, aiming to ensure stable supply for patients throughout the year.
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
North Macedonia | 4 | 6.50 | 0.51% | +20% | 2,083,374 | 12,707 | $12,800 | 78$ |
Totals | 4 | 2,083,374 | 12,707 | $12,800 | 78$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
North Macedonia:
Sasho Klekovski stated that there have been no reports of unnecessary surgeries so far.
6
North Macedonia:
Sasho Klekovski, the director of the Health Fund, visited the General Hospital in Kochani to provide updates on the injured.
7
North Macedonia:
Sasho Klekovski is the director of the Health Insurance Fund and spoke at a press conference regarding the internal commission's work.
7
North Macedonia:
Sasho Klekovski is the director of the Health Insurance Fund.
6
North Macedonia:
Sasho Klekovski, the director of the Health Insurance Fund of Macedonia, urged citizens who believe they have been harmed in cardiology to file complaints.
7
North Macedonia:
Director of the Health Insurance Fund, Sasho Klekovski, was also in attendance.
6
North Macedonia:
Sasho Klekovski is the Director of the Health Insurance Fund present at the hospital department opening.
6
North Macedonia:
Sasho Klekovski announced that all employees working under contract in hospitals will receive permanent contracts after the elections.
8
North Macedonia:
Sasho Klekovski is the general director of the Health Fund.
7
North Macedonia:
Sasho Klekovski is one of the general directors of the Health Insurance Fund who announced the changes in the biomedical assisted reproduction policy.
8